Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07313410

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Near-Infrared Diffuse Correlation Spectroscopy to Better Define the Pathophysiology of Peripheral Artery Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
The University of Texas at Arlington · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Detailed description

Subjects that do not have peripheral artery disease will complete the study procedures up to two times (baseline and follow-up at 1-2 months). Subjects diagnosed with peripheral artery disease may be asked to complete the study procedures up to 4 separate times (baseline, follow-up at 1-2 weeks, 1-2 months, and 4-6 months). The investigators will work with them to schedule each visit. All participants will provide informed consent prior to participating in the study. The screening procedures will include collecting information about health history, age, sex, race/ethnicity, height, weight, and reasons one should not undergo an MRI or exercise. The laboratory procedures will include questionnaires about quality of life and walking ability, Ankle- Brachial Index, functional performance measures (treadmill walking and six minute walk distance), wearable activity monitor and activity log, and lower limb MRI with muscle perfusion and oxygenation measures at rest and in response to physiologic provocation (ischemia-reperfusion and exercise). Investigators may ask subjects to return on a separate day to repeat part, or all, of the study procedures depending on image quality and/or equipment performance.

Conditions

Timeline

Start date
2025-11-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2026-01-02
Last updated
2026-01-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07313410. Inclusion in this directory is not an endorsement.